Researchers have stated that the risk of heart disease and death was increased among people who used a diabetes drug.

As compared to people on other drug, there was a 14 per cent more chance of dying among people who used Avandia, a study of more than 800,000 patients stated. Congestive chances were 23 per cent more in people who took Avandia.

There was a growing concern about these risks and following this, it was taken off the shelves from the market by European safety chiefs.

Reports state that some people in the UK might still be taking the drug and it could not be figured out that what was the effect’s duration among people who took Avandia and if people who ever it were still facing some risk.

There is a lot of evidence against Avandia, known medically as rosiglitazone, and these findings just mean more evidence against it now.

People who were more than 60 and were on Avandia and another drug were analyzed by researchers for a study of 429,000 people who were on Avandia and 381,000 taking Actos or pioglitazone.

In people who took Avandia rather than Actos, for every 100,000 patients, there were 170 more heart attacks in certain groups of patients, 649 excess cases of heart failure and 431 excess deaths.